{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:52:51Z","timestamp":1792633971235,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00595-021-02325-2","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T10:03:21Z","timestamp":1623837801000},"page":"215-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Risk of carcinogenesis in the biliary epithelium of children with congenital biliary dilatation through epigenetic and genetic regulation"],"prefix":"10.1007","volume":"52","author":[{"given":"Hiroki","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Masahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Morine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"issue":"5","key":"2325_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00534-002-0741-7","volume":"10","author":"S Tashiro","year":"2003","unstructured":"Tashiro S, Imaizumi T, Ohkawa H, Okada A, Katoh T, Kawaharada Y, et al. Pancreaticobiliary maljunction: retrospective and nationwide survey in Japan. J Hepatobiliary Pancreat Surg. 2003;10(5):345\u201351.","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"6","key":"2325_CR2","first-page":"1693","volume":"10","author":"A Tsuchida","year":"2003","unstructured":"Tsuchida A, Itoi T, Aoki T, Koyanagi Y. Carcinogenetic process in gallbladder mucosa with pancreaticobiliary maljunction. Oncol Rep. 2003;10(6):1693\u20139.","journal-title":"Oncol Rep"},{"issue":"1","key":"2325_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00423-008-0336-0","volume":"394","author":"T Funabiki","year":"2009","unstructured":"Funabiki T, Matsubara T, Miyakawa S, Ishihara S. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy. Langenbecks Arch Surg. 2009;394(1):159\u201369.","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"2325_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<267::AID-CNCR10>3.0.CO;2-R","volume":"83","author":"S Tanno","year":"1998","unstructured":"Tanno S, Obara T, Fujii T, Mizukami Y, Shudo R, Nishino N, et al. Proliferative potential and k-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. Cancer. 1998;83(2):267\u201375.","journal-title":"Cancer"},{"issue":"1","key":"2325_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00268-001-0187-0","volume":"26","author":"M Nagai","year":"2002","unstructured":"Nagai M, Watanabe M, Iwase T, Yamao K, Isaji S. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction. World J Surg. 2002;26(1):91\u20138.","journal-title":"World J Surg"},{"issue":"3","key":"2325_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s005340200035","volume":"9","author":"T Matsubara","year":"2002","unstructured":"Matsubara T, Sakurai Y, Zhi L-Z, Miura H, Ochiai M, Funabiki T. K-ras and p-53 gene mutations in noncancerous biliary lesions of patients with pancreatico biliary maljunction. J Hepatobiliary Pancreat Surg. 2002;9(3):312\u201321.","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"1","key":"2325_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0016-5107(04)01290-8","volume":"60","author":"T Kamisawa","year":"2004","unstructured":"Kamisawa T, Funata N, Hayashi Y, Egawa N, Nakajima H, Tsuruta K, et al. Pathologic changes in the non-carcinomatous epithelium of the gallbladder in patients with a relatively long common channel. Gastrointest Endosc. 2004;60(1):56\u201360.","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"2325_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrg2485","volume":"10","author":"M Haberland","year":"2009","unstructured":"Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009;10(1):32\u201342.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2325_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc1779","volume":"6","author":"S Minucci","year":"2006","unstructured":"Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer. 2006;6(1):38\u201351.","journal-title":"Nat Rev Cancer"},{"issue":"37","key":"2325_CR10","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","volume":"26","author":"MA Glozak","year":"2007","unstructured":"Glozak MA, Seto E. Histone deacetylases and cancer. Oncogene. 2007;26(37):5420\u201332.","journal-title":"Oncogene"},{"issue":"3","key":"2325_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1006\/bbrc.2001.5639","volume":"287","author":"SK Patra","year":"2001","unstructured":"Patra SK, Patra A, Dahiya R. Histone deacetylase and DNA methyltransferase in human prostate cancer. Biochem Biophys Res Commun. 2001;287(3):705\u201313.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2325_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1535-6108(04)00114-X","volume":"5","author":"P Zhu","year":"2004","unstructured":"Zhu P, Martin E, Mengwasser J, Schlag P, Janssen KP, G\u00f6ttlicher M. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell. 2004;5(5):455\u201363.","journal-title":"Cancer Cell"},{"issue":"6669","key":"2325_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/35895","volume":"391","author":"RJ Lin","year":"1998","unstructured":"Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr, Evans RM. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature. 1998;391(6669):811\u20134.","journal-title":"Nature"},{"issue":"106","key":"2325_CR14","first-page":"472","volume":"58","author":"T Miyatani","year":"2011","unstructured":"Miyatani T, Kurita N, Mikami C, Kashihara H, Higashijima J, Yoshikawa K, et al. Malignant potential of Barrett\u2019s esophagus: special reference to HDAC-1 and MTA-1 expression. Hepatogastroenterology. 2011;58(106):472\u20136.","journal-title":"Hepatogastroenterology"},{"issue":"6944","key":"2325_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature01707","volume":"424","author":"H Zhang","year":"2003","unstructured":"Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature. 2003;424(6944):94\u20138.","journal-title":"Nature"},{"key":"2325_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.immunol.20.090501.112049","volume":"20","author":"T Honjo","year":"2002","unstructured":"Honjo T, Kinoshita K, Muramatsu M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol. 2002;20:165\u201396.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"2325_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0168-9525(03)00054-4","volume":"19","author":"JE Wedekind","year":"2003","unstructured":"Wedekind JE, Dance GS, Sowden MP, Smith HC. Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. Trends Genet. 2003;19(4):207\u201316.","journal-title":"Trends Genet"},{"issue":"11","key":"2325_CR18","doi-asserted-by":"publisher","first-page":"6513","DOI":"10.4049\/jimmunol.172.11.6513","volume":"172","author":"M Cascalho","year":"2004","unstructured":"Cascalho M. Advantages and disadvantages of cytidine deamination. J Immunol. 2004;172(11):6513\u20138.","journal-title":"J Immunol"},{"issue":"3","key":"2325_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1532\/IJH97.06011","volume":"83","author":"K Kinoshita","year":"2006","unstructured":"Kinoshita K, Nonaka T. The dark side of activation-induced cytidine deaminase: relationship with leukemia and beyond. Int J Hematol. 2006;83(3):201\u20137.","journal-title":"Int J Hematol"},{"issue":"4","key":"2325_CR20","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nm1566","volume":"13","author":"Y Matsumoto","year":"2007","unstructured":"Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T, et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med. 2007;13(4):470\u20136.","journal-title":"Nat Med"},{"issue":"8","key":"2325_CR21","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/02841860601043066","volume":"45","author":"M Li","year":"2006","unstructured":"Li M, Liu W, Zhu YF, Chen YL, Zhang BZ, Wang R. Correlation of COX-2 and K-ras expression to clinical outcome in gastric cancer. Acta Oncol. 2006;45(8):1115\u20139.","journal-title":"Acta Oncol"},{"issue":"9","key":"2325_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1600-0714.2011.01031.x","volume":"40","author":"S Theocharis","year":"2011","unstructured":"Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, et al. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. J Oral Pathol Med. 2011;40(9):706\u201314.","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"2325_CR23","doi-asserted-by":"publisher","first-page":"e62066","DOI":"10.1371\/journal.pone.0062066","volume":"8","author":"Y Nakanishi","year":"2013","unstructured":"Nakanishi Y, Kondo S, Wakisaka N, Tsuji A, Endo K, Murono S, et al. Role of activation-induced cytidine deaminase in the development of oral squamous cell carcinoma. PLoS ONE. 2013;8(4):e62066.","journal-title":"PLoS ONE"},{"issue":"18 Pt 1","key":"2325_CR24","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1158\/1078-0432.CCR-04-0202","volume":"10","author":"AM Gonzalez-Angulo","year":"2004","unstructured":"Gonzalez-Angulo AM, Sneige N, Buzdar AU, Valero V, Kau SW, Broglio K, et al. p53 expression as a prognostic marker in inflammatory breast cancer. Clin Cancer Res. 2004;10(18 Pt 1):6215\u201321.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2325_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2302\/kjm.38.167","volume":"38","author":"T Kato","year":"1989","unstructured":"Kato T, Matsuda K, Kayaba H, Enomoto S, Hebiguchi T, Koyama K, et al. Pathology of anomalous junction of the pancreaticobiliary ductal system: mutagenicity of the contents of the biliary tract and nuclear atypia of the biliary epithelium. Keio J Med. 1989;38(2):167\u201376.","journal-title":"Keio J Med"},{"issue":"1","key":"2325_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00534-008-0010-5","volume":"16","author":"T Kamisawa","year":"2009","unstructured":"Kamisawa T, Kurata M, Honda G, Tsuruta K, Okamoto A. Biliopancreatic reflux-pathophysiology and clinical implications. J Hepatobiliary Pancreat Surg. 2009;16(1):19\u201324.","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"3","key":"2325_CR27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/hep.1840130310","volume":"13","author":"K Shimada","year":"1991","unstructured":"Shimada K, Yanagisawa J, Nakayama F. Increased lysophosphatidylcholine and pancreatic enzyme content in bile of patients with anomalous pancreaticobiliary ductal junction. Hepatology. 1991;13(3):438\u201344.","journal-title":"Hepatology"},{"issue":"3","key":"2325_CR28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4251\/wjgo.v2.i3.130","volume":"2","author":"A Tsuchida","year":"2010","unstructured":"Tsuchida A, Itoi T. Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction. World J Gastrointest Oncol. 2010;2(3):130\u20135.","journal-title":"World J Gastrointest Oncol"},{"issue":"2","key":"2325_CR29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00535-016-1268-z","volume":"52","author":"T Kamisawa","year":"2017","unstructured":"Kamisawa T, Kuruma S, Chiba K, Tabata T, Koizumi S, Kikuyama M. Biliary carcinogenesis in pancreaticobiliary maljunction. J Gastroenterol. 2017;52(2):158\u201363.","journal-title":"J Gastroenterol"},{"issue":"5","key":"2325_CR30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00534-013-0606-2","volume":"20","author":"Y Morine","year":"2013","unstructured":"Morine Y, Shimada M, Takamatsu H, Araida T, Endo I, Kubota M, et al. Clinical features of pancreaticobiliary maljunction: update analysis of 2nd Japan-nationwide survey. J Hepatobiliary Pancreat Sci. 2013;20(5):472\u201380.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"3","key":"2325_CR31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<452::AID-CNCR5>3.0.CO;2-M","volume":"77","author":"K Hanada","year":"1996","unstructured":"Hanada K, Itoh M, Fujii K, Tsuchida A, Ooishi H, Kajiyama G. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer. 1996;77(3):452\u20138.","journal-title":"Cancer"},{"issue":"8","key":"2325_CR32","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1440-1746.2004.03355.x","volume":"19","author":"MK Singh","year":"2004","unstructured":"Singh MK, Chetri K, Pandey UB, Kapoor VK, Mittal B, Choudhuri G. Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer. J Gastroenterol Hepatol. 2004;19(8):916\u201321.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"2325_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s004230100220","volume":"386","author":"S Tazuma","year":"2001","unstructured":"Tazuma S, Kajiyama G. Carcinogenesis of malignant lesions of the gall bladder: the impact of chronic inflammation and gallstones. Langenbecks Arch Surg. 2001;386(3):224\u20139.","journal-title":"Langenbecks Arch Surg"},{"issue":"6","key":"2325_CR34","first-page":"1211","volume":"91","author":"H Tomono","year":"1996","unstructured":"Tomono H, Nimura Y, Aono K, Nakashima I, Iwamoto T, Nakashima N. Point mutations of the c-Ki-ras gene in carcinoma and atypical epithelium associated with congenital biliary dilatation. Am J Gastroenterol. 1996;91(6):1211\u20134.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2325_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s005340050120","volume":"6","author":"T Matsubara","year":"1999","unstructured":"Matsubara T, Funabiki T, Jinno O, Sakurai Y, Hasegawa S, Imazu H, et al. p53 gene mutations and overexpression of p53 product in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg. 1999;6(3):286\u201393.","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"9","key":"2325_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrc1429","volume":"4","author":"II Wistuba","year":"2004","unstructured":"Wistuba II, Gazdar AF. Gallbladder cancer: lessens from rare tumour. Nat Rev Cancer. 2004;4(9):695\u2013706.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2325_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canlet.2008.10.047","volume":"280","author":"W Weichert","year":"2009","unstructured":"Weichert W. HDAC expression and clinical prognosis in human malignancies. Cancer Lett. 2009;280(2):168\u201376.","journal-title":"Cancer Lett"},{"issue":"6","key":"2325_CR38","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/1940-6207.CAPR-14-0286","volume":"8","author":"S Shukla","year":"2015","unstructured":"Shukla S, Khan S, Kumar S, Sinha S, Farhan M, Bora HK, et al. Cucurbitacin B alters the expression of tumor-related genes by epigenetic modifications in NSCLC and inhibits NNK-induced lung tumorigenesis. Cancer Prev Res (Phila). 2015;8(6):552\u201362.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"2325_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.bbrc.2004.03.066","volume":"317","author":"X Tong","year":"2004","unstructured":"Tong X, Yin L, Giardina C. Butylrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition. Biochem Biophys Res Commun. 2004;317(2):463\u201371.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2325_CR40","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ijc.25367","volume":"128","author":"A Biran","year":"2011","unstructured":"Biran A, Brownstein M, Haklai R, Kloog Y. Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy. Int J Cancer. 2011;128(3):691\u2013701.","journal-title":"Int J Cancer"},{"issue":"3","key":"2325_CR41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10585-008-9233-8","volume":"26","author":"Y Toh","year":"2009","unstructured":"Toh Y, Nicolson GL. The role of the MTA family and their encoded proteins in humancancers: molecular functions and clinical implications. Clin Exp Metastasis. 2009;26(3):215\u201327.","journal-title":"Clin Exp Metastasis"},{"issue":"3","key":"2325_CR42","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1245\/s10434-006-9294-3","volume":"14","author":"K S\u00f8reide","year":"2007","unstructured":"S\u00f8reide K, S\u00f8reide JA. Bile duct cyst as precursor to biliary tract cancer. Ann Surg Oncol. 2007;14(3):1200\u201311.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"2325_CR43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nri1395","volume":"4","author":"J Chaudhuri","year":"2004","unstructured":"Chaudhuri J, Alt FW. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol. 2004;4(7):541\u201352.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2325_CR44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","volume":"102","author":"M Muramatsu","year":"2000","unstructured":"Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000;102(5):553\u201363.","journal-title":"Cell"},{"issue":"3","key":"2325_CR45","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1053\/j.gastro.2008.06.091","volume":"135","author":"Y Endo","year":"2008","unstructured":"Endo Y, Marusawa H, Kou T, Nakase H, Fujii S, Fujimori T, et al. Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. Gastroenterology. 2008;135(3):889\u201398.","journal-title":"Gastroenterology"},{"issue":"3","key":"2325_CR46","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/hep.22125","volume":"47","author":"J Komori","year":"2008","unstructured":"Komori J, Marusawa H, Machimoto T, Endo Y, Kinoshita K, Kou T, et al. Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma. Hepatology. 2008;47(3):888\u201396.","journal-title":"Hepatology"},{"issue":"11","key":"2325_CR47","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/carcin\/bgr194","volume":"32","author":"S Morita","year":"2011","unstructured":"Morita S, Matsumoto Y, Okuyama S, Ono K, Kitamura Y, Tomori A, et al. Bile acid-induced expression of activationinduced cytidine deaminase during the development of Barrett\u2019s oesophageal adenocarcinoma. Carcinogenesis. 2011;32(11):1706\u201312.","journal-title":"Carcinogenesis"},{"issue":"3","key":"2325_CR48","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ijc.22292","volume":"120","author":"T Kou","year":"2007","unstructured":"Kou T, Marusawa H, Kinoshita K, Endo Y, Okazaki IM, Ueda Y, et al. Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis. Int J Cancer. 2007;120(3):469\u201376.","journal-title":"Int J Cancer"},{"issue":"12","key":"2325_CR49","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/ijc.23853","volume":"123","author":"T Morisawa","year":"2008","unstructured":"Morisawa T, Marusawa H, Ueda Y, Iwai A, Okazaki IM, Honjo T, et al. Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression. Int J Cancer. 2008;123(12):2735\u201340.","journal-title":"Int J Cancer"},{"issue":"6","key":"2325_CR50","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/S0022-3468(99)90769-8","volume":"34","author":"S Ono","year":"1999","unstructured":"Ono S, Tokiwa K, Iwai N. Cellular activity in the gallbladder of children with anomalous arrangement of the pancreaticobiliary duct. J pediatr surg. 1999;34(6):962\u20136.","journal-title":"J pediatr surg"},{"issue":"11","key":"2325_CR51","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.jpedsurg.2009.06.037","volume":"44","author":"N Saikusa","year":"2009","unstructured":"Saikusa N, Naito S, Iinuma Y, Ohtani T, Yokoyama N, Nitta K. Invasive cholangiocarcinoma identified in congenital biliary dilatation in a 3-year-old boy. J Pediatr Surg. 2009;44(11):2202\u20135.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"2325_CR52","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s00534-007-1310-x","volume":"15","author":"H Nakamura","year":"2008","unstructured":"Nakamura H, Katayose Y, Rikiyama T, Onogawa T, Yamamoto K, Yoshida H, et al. Advanced bile duct carcinoma in a 15-year-old patient with pancreaticobiliary maljunction and congenital biliary cystic disease. J Hepatobiliary Pancreat Surg. 2008;15(5):554\u20139.","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"1","key":"2325_CR53","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.jpedsurg.2005.10.066","volume":"41","author":"S Tanaka","year":"2006","unstructured":"Tanaka S, Kubota M, Yagi M, Okuyama N, Ohtaki M, Yamazaki S, et al. An 11-year-old male patient demonstrating cholangiocarcinoma associated with congenital biliary dilatation. J Pediatr Surg. 2006;41(1):e15\u20139.","journal-title":"J Pediatr Surg"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-021-02325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-021-02325-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-021-02325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T01:08:37Z","timestamp":1675472917000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-021-02325-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["2325"],"URL":"https:\/\/doi.org\/10.1007\/s00595-021-02325-2","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol for this research project was approved by the Ethics Committee of our institution (No. 3010) and conforms to the provisions of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statements"}}]}}